A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS
暂无分享,去创建一个
S. Purcell | A. Al-Chalabi | C. Shaw | S. Cronin | O. Hardiman | J. Landers | V. Meininger | J. Melki | L. H. van den Berg | M. V. van Es | D. Kasperavičiūtė | G. Rouleau | K. Morrison | P. Shaw | P. Valdmanis | D. Figlewicz | R. Pamphlett | P. Andersen | A. Slowik | J. Morahan | R. H. Brown | E. Fisher | A. Wills | M. A. Es | P. Shaw | Guy A. Rouleau | Christopher Shaw | Pamela J. Shaw | Peter M Andersen | Shaun Purcell | V. Meininger | A-M. Wills | Simon Cronin | Agnieszka Slowik | Elizabeth M. C. Fisher | L. H. V. D. Berg | Orla Hardiman | Robert H. Brown
[1] Robert A Gross,et al. Levels of evidence , 2008, Neurology.
[2] G. Gronseth,et al. Lost in a jungle of evidence: we need a compass. , 2008, Neurology.
[3] G. Gronseth,et al. Invited Article: Practice parameters and technology assessments , 2008, Neurology.
[4] P. Andersen,et al. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden , 2008, Neurology.
[5] Robert H. Brown,et al. A common haplotype within the PON1 promoter region is associated with sporadic ALS , 2008, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[6] Orla Hardiman,et al. A genome-wide association study of sporadic ALS in a homogenous Irish population. , 2007, Human molecular genetics.
[7] Frank Baas,et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis , 2008, Nature Genetics.
[8] B. Traynor,et al. Genetics of sporadic amyotrophic lateral sclerosis. , 2007, Human molecular genetics.
[9] R. Ophoff,et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study , 2007, The Lancet Neurology.
[10] K. Shianna,et al. Large-scale pathways-based association study in amyotrophic lateral sclerosis. , 2007, Brain : a journal of neurology.
[11] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[12] Kuixing Zhang,et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. , 2007, The New England journal of medicine.
[13] S. Cronin,et al. Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis , 2007, Journal of Neurology, Neurosurgery & Psychiatry.
[14] R. Trent,et al. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. , 2007, Neurotoxicology.
[15] Sonja W. Scholz,et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.
[16] A. Al-Chalabi,et al. Amyotrophic lateral sclerosis as a complex genetic disease. , 2006, Biochimica et biophysica acta.
[17] J. Haines,et al. Paraoxonase cluster polymorphisms are associated with sporadic ALS , 2006, Neurology.
[18] M. Małecki,et al. Paraoxonase gene polymorphisms and sporadic ALS , 2006, Neurology.
[19] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[20] Robert H. Brown,et al. Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS) , 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[21] K. Lunetta,et al. Polymorphisms in the PON gene cluster are associated with Alzheimer disease. , 2006, Human molecular genetics.
[22] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[23] J. Witte,et al. Comparison of missing data approaches in linkage analysis , 2003, BMC Genetics.
[24] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[25] Pak Chung Sham,et al. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..
[26] P. Durrington,et al. The paraoxonase gene family and coronary heart disease , 2002, Current opinion in lipidology.
[27] G. Jarvik,et al. Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. , 2001, American journal of human genetics.
[28] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[29] J. Ioannidis,et al. Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.
[30] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[31] G. Belle,et al. Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. , 1997, American journal of epidemiology.
[32] M. Keifer,et al. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin , 1996, Nature Genetics.
[33] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[34] A. Motulsky,et al. Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/arylesterase. , 1989, Analytical biochemistry.
[35] A. Emery,et al. The epidemiology of motor neuron disease in Scotland , 1982, Muscle & nerve.
[36] Mulder Dw. Clinical limits of amyotrophic lateral sclerosis. , 1982 .
[37] E. Granieri,et al. STUDIES ON EPIDEMIOLOGICAL, CLINICAL AND ETIOLOGICAL ASPECTS OF ALS DISEASE IN SARDINIA, SOUTHERN ITALY , 1977, Acta neurologica Scandinavica.
[38] W. Aldridge. Serum esterases. II. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. , 1953, The Biochemical journal.